Biora Therapeutics undertakes Chapter 11 sale process to position business for future growth.

Learn more
Biora Therapeutics Home
Activate the mobile navigation

Publications

Evaluation of the pharmacokinetics of GLP-1 receptor agonist delivered through the BioJet™ oral biotherapeutic delivery platform in a porcine model: an update
#BioJet Oral Therapeutic Delivery
Evaluation of the pharmacokinetics of GLP-1 receptor agonist delivered through the BioJet™ oral biotherapeutic delivery platform in a porcine model
#BioJet Oral Therapeutic Delivery
Evaluation of the pharmacokinetics of PGN-OB1 following oral administration of an oral biotherapeutics delivery system (OBDS) in Yucatan swine
#BioJet Oral Therapeutic Delivery
Development of ex-vivo and in-vivo models to assess the performance of an oral biotherapeutic delivery system (OBDS) capsule
#BioJet Oral Therapeutic Delivery
Development of preclinical models to assess the performance of the oral biotherapeutic delivery system (OBDS) capsule
#BioJet Oral Therapeutic Delivery